ATMU vs BBWI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits weak financial health with a Piotroski F-Score of 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, Atmus shows strong profitability metrics including an ROE of 71.52% and solid revenue and earnings growth, supported by a bullish analyst recommendation and consistent earnings beats. Valuation is rich relative to Graham’s defensive standard ($14.97 vs. current price of $56.55), but growth expectations justify a premium. However, bearish insider activity and high leverage temper optimism, creating a mixed outlook.
BBWI's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock appears undervalued based on a low P/E of 6.87 and an intrinsic value estimate of $22.61, close to the current price of $22.20. However, declining revenue and earnings growth, along with negative Price/Book, raise sustainability concerns. While profitability margins and ROA are strong relative to peers, weak recent earnings surprises and bearish technical trends cap upside potential.
Compare Another Pair
Related Comparisons
ATMU vs BBWI: Head-to-Head Comparison
This page compares Atmus Filtration Technologies Inc. (ATMU) and Bath & Body Works, Inc. (BBWI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.